Lantheus Holdings (LNTH) FCF Margin (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly FCF Margin came in at 32.31% in Q1 2026, up 502.0% year-on-year from 5.37% in Q1 2025, and up 121.22% on a QoQ basis from 14.6% in Q4 2025.

Lantheus Holdings (LNTH) FCF Margin (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of FCF Margin data on file, last reported at 32.31% in Q1 2026.

  • On a quarterly basis, FCF Margin rose 502.0% year-over-year to 32.31% in Q1 2026; TTM through Mar 2026 was 24.2%, a 970.0% decrease from a year earlier, with the FY2025 full-year figure at 22.97%, down 1222.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 32.31%, up from 14.6% in the prior quarter.
  • Over the last five years, FCF Margin for LNTH reached as high as 1004.36% in Q4 2023 and fell as low as 13.58% in Q2 2023.
  • Historically, FCF Margin has averaged 83.96% across 5 years, with a median of 30.51% in 2022.
  • Across the five-year window, FCF Margin jumped 97130 bps in 2023 and sank 94464 bps in 2024, its largest moves.
  • Year by year, FCF Margin stood at 33.06% in 2022, then jumped by 2938 bps to 1004.36% in 2023, then tumbled by 94 bps to 59.72% in 2024, then plunged by 76 bps to 14.6% in 2025, then surged by 121 bps to 32.31% in 2026.
  • Per Business Quant data, the three most recent FCF Margin figures were 32.31% in Q1 2026, 14.6% in Q4 2025, and 26.03% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -5.22%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 12.86%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5.35%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 46.54%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 9.93%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 17.73%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.77%
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 32.31%

Historic Data

Download Data
DateValue
Mar 31, 2026 32.31%
Dec 31, 2025 14.60%
Sep 30, 2025 26.03%
Jun 30, 2025 24.59%
Mar 31, 2025 27.28%
Dec 31, 2024 59.72%
Sep 30, 2024 33.81%
Jun 30, 2024 14.63%
Mar 31, 2024 32.54%
Dec 31, 2023 1,004.36%
Sep 30, 2023 28.52%
Jun 30, 2023 -13.58%
Mar 31, 2023 33.27%
Dec 31, 2022 33.06%
Sep 30, 2022 42.25%
Jun 30, 2022 30.51%
Mar 31, 2022 3.39%
Dec 31, 2021 1.35%
Sep 30, 2021 4.25%
Jun 30, 2021 25.60%